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In their insightful paper, Yano and collaborators (1) have recently reported thatoutbred CD-1 mice are resistant to chronic vaginal infection (vulvovaginal candidiasis
[VVC]), presumably due to an inherent nonresponsiveness to estrogen treatment (2). In
view of the importance of establishing a mouse model of resistance to VVC (rVVC) in
animals with the genetic heterogeneity and variable individual susceptibility to infec-
tion that also characterizes human vaginal infection (3), we examined whether rVVC
could also be induced in CD-1 mice in a vis-a-vis comparison with typically VVC-
susceptible C57BL/6J mice.
We initially determined infectious burden and vaginal inﬂammatory markers
(neutrophils and interleukin-1 [IL-1]) on different days post-infection in mice
infected with different doses of Candida albicans (for experimental details, see
reference 4 and the legend to Fig. 1). Here we conﬁrm the data reported by Yano
et al. (1) that at a relatively low challenge dose (around or below 105 fungal cells),
the intravaginal fungal CFU were comparable in the two strains of mice until day 3
but decreased dramatically in CD-1 mice on the following days. However, when
infected by 2  107 cells, CD-1 and C57BL/6J mice had similar degrees of infection
and inﬂammation throughout the observation period (up to 14 days; data not
shown). This suggested that the early loss of infection in the outbred mice could be
due to an insufﬁcient challenge dose. Thus, CD-1 and C57BL/6J mice were chal-
lenged with 2  106 fungal cells, keeping all other conditions unchanged (as in
previous experiments [4]), and prolonging the observation period until day 26 after
challenge.
Figure 1 shows the cumulative data from two experiments. Vaginal fungus loads
(Fig. 1A) were consistently and persistently high in all mice, with no signiﬁcant
difference between CD-1 and C57BL/6J mouse strains except on day 26, when no CFU
were recovered from two of the ﬁve CD-1 mice. However, the other three mice had CFU
counts quite comparable to those of the C57BL/6J mice (4.6  0.12 versus 5.1  0.05
[mean log CFU/g of tissue  SEM]). Notably, both neutrophil numbers (Fig. 1B) and
IL-1 concentrations in the vaginal ﬂuid (Fig. 1C) were similar overall in the two strains
of mice on each day examined, including day 26, with no statistically signiﬁcant
differences between them.
The experiments described above show that CD-1 mice are not inherently refractory
to persistent vaginal infection and inﬂammation by C. albicans. Their reported resis-
tance to VVC (1) can be overcome by increasing the size of the infectious inoculum,
which could make the estrogen requirement less stringent (2). Mechanistically, the data
obtained so far in our CD-1 model infected with high fungal inoculum are consistent
with the well-established features of experimental vaginal candidiasis in typically
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susceptible mice: high levels of inﬂammatory markers, inability of the massively re-
cruited neutrophils to clear the infection, possibly due to Candida or host-derived
inhibitors, and role of one or more fungal aspartyl proteinases as inﬂammation inducers
(1, 4–7).
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